A device for catheterization is disclosed. Such a device includes a hollow catheter, a cylindrical sheath, and a flange through which the catheter passes. Before insertion, the sheath begins at a first opening near the catheter tip and extends into the catheter to a first circumferential fold, then back towards the catheter tip to a second circumferential fold about the tip to the exterior surface, and ends at a second opening attached to the flange. As the device is inserted up to a length, the flange abuts the cavity opening, and a corresponding length of the sheath deploys from the catheter interior, around the first and second circumferential folds, to the catheter outer surface. Once fully inserted, all, or a substantial portion, of the sheath initially positioned within the catheter has been deployed to the outer surface, thereby forming a protective barrier between the catheter and the surrounding tissues.

A female urethral catheterization assist device is provided. The female urethral catheterization assist device includes a first lateral arm pivotally secured to a second lateral arm. Each lateral arm includes a platform placed opposite a handle. A paddle extends upward from each platform on an interior lateral side of each platform. The paddles are designed to engage the labia minora and labia majora of a patient and to assist with urethral catheterization.

An intermittent catheter, preferably a female intermittent catheter, is provided in an assembly. The assembly may include a cap which may be attachable to the base of the assembly in use, and/or a seal which misaligns with sealing surfaces of a chamber wall and a moveable insert in use. It may have a two-step deployment, and/or a sheath that pulls out a storage chamber. Internal and external housing may define the storage chamber. The housing may have a filling aperture and/or the storage chamber may comprise an insert configured to move axially in response to rotation.

An intermittent catheter, preferably a female intermittent catheter, is provided in an assembly. The assembly may include a cap which may be attachable to the base of the assembly in use, and/or a seal which misaligns with sealing surfaces of a chamber wall and a moveable insert in use. It may have a two-step deployment, and/or a sheath that pulls out a storage chamber. Internal and external housing may define the storage chamber. The housing may have a filling aperture and/or the storage chamber may comprise an insert configured to move axially in response to rotation.

A female urinary catheter deployment device includes a housing, an inner tip, an outer tip, a catheter, and an actuator. The outer tip is moved into the vicinity of the urethral opening of a female urethra. The outer tip is then moved from a closed condition to an open condition so as to expose a proximal end of the inner tip and position the proximal end of the inner tip within the urethra. The actuator is then moved with respect to the housing so as to proximally advance a proximal end of the catheter through and out of the proximal end of the inner tip and into the urethra. The proximal end of the catheter is further advanced through the urethra and into the bladder so as to drain urine from the bladder, through the catheter, and out of the housing.

A closed-system urinary catheter with a low viscosity gel lubrication is disclosed. The system has an uncoated catheter, but a hydrophilic coated catheter could be used. The low viscosity lubricating gel within the sachet uniformly coats the catheter when the sachet is ruptured just prior to use. A low viscosity lubrication gel could alternatively be place in the area inside the sheath and external to the catheter. Therefore, the variability that occurs with a hydrophilic catheter or the areas of a non-lubricated catheter with the higher viscosity gel catheters is avoided.

Devices and methods are described for injecting therapeutics into tissue. For example, some embodiments disclosed in this document describe devices and methods for injecting muscle precursor cells into the sphincter urethrae to treat stress urinary incontinence.

A female smart wearable system for management of urine incontinence comprising of a female urinary external catheter to allow urine to drain without obstruction, provided with a stabilizer for supporting and bounding/confining the external catheter in the contour of female genitalia and a urine collection device which is either having a plurality of vertical chambers for collecting urine as well as supplying fluid to keep the subject clean in a more convenient and hygienic way or is having a disposable pad for female subject with moderate or low urinary incontinence. The female smart wearable system is worn by the female subject in an underwear integrated with plurality of sensors that provide data to help in understanding and preventing the problem of urine incontinence. The female smart wearable system integrates provision of washing inside the device and use of disposable pads makes it cost effective and reusable.

A self-placeable external catheter is disclosed that includes a catheter body having at least a top side and a bottom, a wicking area disposed on the top side, a finger covering extending from the bottom side of the catheter body creating a cavity configured to receive a user finger, and an aperture formed in the bottom side of the catheter, wherein the wicking area receives urine such that the urine passes through the wicking area, through the catheter body and through the aperture. The catheter tubing may be inserted into the aperture such that the urine passes through the wicking area, through the catheter body and through the aperture into the catheter tubing. An opening of the cavity may face a proximal side of the catheter body and the wicking area may include gauze.

An intermittent urinary catheterisation aid 2 and an assembly is provided. The aid allows a user to manipulate an intermittent urinary catheter 3 in one direction and insert it into the urethra in another direction.